140 purchase as supplier for a total of 623,992.7 between 2009 and 2011.
Overcost in MXN
247,518 pesos mexicanos
Overcost in %
1,091.3 %
| Product | Purchases | Total amount | Overcost in MXN | Overcost in % | Period |
|---|---|---|---|---|---|
| LOSARTÁN | 10 | 23,067.2 MXN | 22,398 MXN | 3,347.2 % | 2010 - 2010 |
| RALOXIFENO | 9 | 23,552 MXN | 13,826.3 MXN | 148.2 % | 2010 - 2010 |
| INSULINA GLARGINA | 8 | 22,798 MXN | 5,603.3 MXN | 32.6 % | 2010 - 2010 |
| LEVOMEPROMAZINA | 7 | 4,281.6 MXN | 3,600.1 MXN | 502.2 % | 2009 - 2010 |
| WARFARINA | 6 | 10,563.2 MXN | 9,813.3 MXN | 1,381 % | 2010 - 2010 |
| CLONAZEPAM | 6 | 11,017.1 MXN | 10,347.4 MXN | 1,545.1 % | 2010 - 2010 |
| AMIODARONA | 5 | 2,850 MXN | 2,491.5 MXN | 694.9 % | 2010 - 2010 |
| INSULINA LISPRO LISPRO PROTAMINA | 4 | 3,245.7 MXN | 1,125.7 MXN | 35.8 % | 2010 - 2010 |
| LEVETIRACETAM | 3 | 13,964.4 MXN | 9,166.5 MXN | 191.1 % | 2010 - 2010 |
| ÁCIDO RISEDRÓNICO | 3 | 5,021.3 MXN | 0 MXN | 0 % | 2010 - 2010 |
Country
Entity type
profit
Identifiers
RFC: FAR000707RC3
Source(s)
Part of the project
Organization responsible for the import